PHA-739358

DRUG2 trials

Sponsors

Nerviano Medical Sciences

Conditions

Metastatic Hormone Refractory Prostate CancerMultiple Myeloma

Phase 2

PHA-739358 for Treatment of Hormone Refractory Prostate Cancer

CompletedNCT00766324

Nerviano Medical SciencesMetastatic Hormone Refractory Prostate Cancer

Start: 2007-09-30End: 2011-04-30Updated: 2014-05-28

PHA-739358 for the Treatment of Multiple Myeloma

TerminatedNCT00872300

Nerviano Medical SciencesMultiple Myeloma

Start: 2008-10-31End: 2010-09-30Updated: 2014-05-28